Młynarska, E.; Bojdo, K.; Frankenstein, H.; Kustosik, N.; Mstowska, W.; Przybylak, A.; Rysz, J.; Franczyk, B.
Nanotechnology and Artificial Intelligence in Dyslipidemia Management—Cardiovascular Disease: Advances, Challenges, and Future Perspectives. J. Clin. Med. 2025, 14, 887.
https://doi.org/10.3390/jcm14030887
AMA Style
Młynarska E, Bojdo K, Frankenstein H, Kustosik N, Mstowska W, Przybylak A, Rysz J, Franczyk B.
Nanotechnology and Artificial Intelligence in Dyslipidemia Management—Cardiovascular Disease: Advances, Challenges, and Future Perspectives. Journal of Clinical Medicine. 2025; 14(3):887.
https://doi.org/10.3390/jcm14030887
Chicago/Turabian Style
Młynarska, Ewelina, Kinga Bojdo, Hanna Frankenstein, Natalia Kustosik, Weronika Mstowska, Aleksandra Przybylak, Jacek Rysz, and Beata Franczyk.
2025. "Nanotechnology and Artificial Intelligence in Dyslipidemia Management—Cardiovascular Disease: Advances, Challenges, and Future Perspectives" Journal of Clinical Medicine 14, no. 3: 887.
https://doi.org/10.3390/jcm14030887
APA Style
Młynarska, E., Bojdo, K., Frankenstein, H., Kustosik, N., Mstowska, W., Przybylak, A., Rysz, J., & Franczyk, B.
(2025). Nanotechnology and Artificial Intelligence in Dyslipidemia Management—Cardiovascular Disease: Advances, Challenges, and Future Perspectives. Journal of Clinical Medicine, 14(3), 887.
https://doi.org/10.3390/jcm14030887